No price history available.
Key financial summary
Financials in ZAC| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ZACm | 18,843 | 21,200 | 21,636 | 23,699 | 25,202 | 26,344 | N/A | N/A |
| Operating profit | ZACm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ZACm | 446 | 769 | 1,013 | 1,257 | 1,499 | 1,743 | N/A | N/A |
| EPS reported | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ZACm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ZACm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ZACm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ZAC | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in ZAC| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Netcare Limited, an investment holding company with its headquarters in Sandton, South Africa, is a prominent operator of private hospitals across the country. The organization's activities are divided into two main segments: Hospital and Emergency Services, and Primary Care. The Hospital and Emergency Services division oversees the company's network of private acute care hospitals, day clinics, and pharmaceutical operations. This segment also provides a range of non-acute services, including emergency medical response, the management of private mental health clinics, and specialized cancer care. Additionally, it offers various healthcare products and vouchers. The Primary Care segment is focused on delivering general healthcare services, employee health and wellness programs, and administrative support for medical and dental practices. Netcare boasts an extensive healthcare infrastructure throughout South Africa, which includes 51 private hospitals, two public-private partnership hospitals, and a total capacity of 10,605 registered beds. Its specialized facilities encompass 10 cancer care centers, 422 operating theaters, and 63 renal dialysis units featuring 860 stations. The primary care network consists of 95 centers and 15 Medicross day theaters, alongside 79 Netcare 911 emergency sites. The company further operates 7 training campuses and 12 mental health and psychiatric clinics, providing 841 beds. Netcare Limited was founded in 1996.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Netcare Limited, an investment holding company with its headquarters in Sandton, South Africa, is a prominent operator of private hospitals across the country. The organization's activities are divided into two main segments: Hospital and Emergency Services, and Primary Care. The Hospital and Emergency Services division oversees the company's network of private acute care hospitals, day clinics, and pharmaceutical operations. This segment also provides a range of non-acute services, including emergency medical response, the management of private mental health clinics, and specialized cancer care. Additionally, it offers various healthcare products and vouchers. The Primary Care segment is focused on delivering general healthcare services, employee health and wellness programs, and administrative support for medical and dental practices. Netcare boasts an extensive healthcare infrastructure throughout South Africa, which includes 51 private hospitals, two public-private partnership hospitals, and a total capacity of 10,605 registered beds. Its specialized facilities encompass 10 cancer care centers, 422 operating theaters, and 63 renal dialysis units featuring 860 stations. The primary care network consists of 95 centers and 15 Medicross day theaters, alongside 79 Netcare 911 emergency sites. The company further operates 7 training campuses and 12 mental health and psychiatric clinics, providing 841 beds. Netcare Limited was founded in 1996.
